Oxford
Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London
April 1, 2026Conferencing, Events & Incentives Cambridge, Cambridge Wide Open Week, London, Oxford
Cambridge Wide Open Week (CWOW) returns from 11-19 June 2026, sharing the spirit and buzz of the week-long, interactive festival …
Oxford University to collaborate with Oracle on COVID variant research
May 17, 2021Sales and Marketing AI, COVID-19, Oxford, variants
In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …
Rising to the challenge of delivering therapeutic discovery for mental disorders
November 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health
Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …
UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres
November 6, 2018Manufacturing and Production, Research and Development AI, Leeds, London, Oxford, UK, glasgow, pharma
The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced …
New AI system for lung cancer and heart disease could save NHS billions
January 4, 2018Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma
A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …
UK pharma’s ‘Golden Triangle’ faces competition from new challengers
June 29, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioGateway, Cambridge, London, Oxford
The UK’s medical and scientific base is regarded as one of the world’s best.
Google backs Oxford Sciences Innovation
June 22, 2015Medical Communications, Sales and Marketing Oxford, Oxford Sciences Innovation, google, ventures
Google has invested into a company that funds spinoffs from Oxford University’s technology and science departments called Oxford Sciences Innovation …
New malaria vaccine found effective in adults
May 8, 2015Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria
A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …
AstraZeneca signs immuno-oncology deal with UK firm
April 16, 2015Research and Development, Sales and Marketing AstraZeneca, IMCgp100, MEDI4736, MedImmune, Oxford, immuno-oncology, immunocore, melanoma, tremelimumab
UK pharma and biotech firms AstraZeneca and Immunocore are teaming up to launch early-stage studies of potential new cancer treatments. …
£30m drug discovery centres launched to overcome pharma ‘funding fatigue’
February 18, 2015Research and Development, Sales and Marketing Alzheimer’s Research UK, Cambridge, London, Oxford, dementia, funding, pharma
Three new drug discovery institutes will be launched in the UK with a £30 million commitment to fast-track the development …
Hormone replacement therapy elevates ovarian cancer risk
February 13, 2015Research and Development, Sales and Marketing Cancer, HRT, Lancet, Oxford, oncology, ovarian
According to a new study women who undergo hormone replacement therapy nearly double their risk of developing ovarian cancer. Findings …
Laser testing could lead to improved asthma therapies
November 13, 2014Research and Development, Sales and Marketing Oxford, asthma, pmdis, pope, stfc
UK scientists have used a laser beam trap to examine how drug particles from asthma inhalers travel through the air …
Lilly signs Immunocore deal
July 17, 2014Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly
Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …
Bayer in Oxford tie-up
July 11, 2014Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university
Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …
UK invests in Oxford bioscience site
January 31, 2014Research and Development, Sales and Marketing Milton Park, Oxford, UK, bioscience, government
The government is putting £7 million into Milton Park, near Oxford, to boost the building of a new laboratory and …
Latest content
FibroFind appoints Lee Borthwick as CEO
